This statute-level amendment revises the Pharmaceutical Services Act to modernize drafting, broaden who may be treated as a prescriber, and adjust the province's tamper‑resistant prescription program to work with federal Controlled Drugs and Substances Act (CDSA) exemptions. It adds a new defined term—"dispensing physician"—and explicitly names pharmacists, registered nurses and midwives among those entitled to prescribe under provincial law.
Beyond definitions, the bill creates targeted operational permissions: it permits pharmacists and dispensing physicians to dispense certain drugs via telephone or to accept transferred prescriptions for controlled substances—but only where a federal CDSA subsection 56(1) exemption authorizes that practice. The text also replaces outdated court references, adopts gender‑neutral wording throughout, and tightens administrative mechanics such as return requirements for tamper‑resistant pads.
At a Glance
What It Does
The bill inserts a new definition for "dispensing physician" and expands the statutory "prescriber" category to include pharmacists, registered nurses and midwives. It adds explicit exceptions allowing telephone dispensing and prescription transfers for drugs on the regulated list when a federal CDSA s.56(1) exemption authorizes those actions.
Who It Affects
Community pharmacists and dispensation services, medical practitioners who dispense in‑office, midwives and registered nurses with prescribing authority, provincial regulatory bodies, and pharmacies that manage tamper‑resistant prescription pads and controlled substances inventories. The provincial department that administers the Act also faces new operational duties.
Why It Matters
It creates a controlled pathway for provincial practice to adapt when federal emergency or temporary exemptions are issued, reducing legal uncertainty for pharmacists and dispensing physicians but also requiring tight compliance with exemption terms. The drafting updates remove obsolete court names and standardize gender‑neutral language, reducing litigation risk from ambiguous wording.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The amendment first inserts a specific statutory category called "dispensing physician": a medical practitioner licensed under the Medical Act, 2011 who dispenses drugs as part of practice. The prescriber definition is broadened beyond traditional prescribers to list specific professions — including pharmacists, registered nurses and midwives — making clear that those professionals are included among people "entitled to prescribe drugs under the laws of the province." That change clarifies who can appear on prescriptions and who the Act treats as a prescriber for licensing and discipline purposes.
On controlled substances and the province's tamper‑resistant prescription pad rules, the Act now accommodates temporary federal authorizations. Two new provincial subsections allow a pharmacist or dispensing physician to dispense a drug by telephone (new s.26(5.1)) or to accept a transferred prescription for a controlled substance (new s.26(6.1)), but only where an exemption under s.56(1) of the federal Controlled Drugs and Substances Act explicitly authorizes the practice.
The amendments require pharmacists and dispensing physicians to follow the terms and duration of any such federal exemption and limit dispensing to the exemption's effective period.The bill also tightens the tamper‑resistant pad program's mechanics: it replaces the old return language so that when a prescriber's licence is suspended, cancelled, or the prescriber stops practising in the province, the prescriber must return all tamper‑resistant prescription pads to the minister within three days. Several appeal and administrative provisions are reworded to replace gendered pronouns with neutral terms, to update cross‑references (including the Public Inquiries Act citation), and to allow appeal boards to proceed in an appellant's absence under specified conditions.
Finally, the statute replaces references to "Trial Division" with "Supreme Court" and modernizes the offence provision in s.47(1) to use neutral, person‑based language.
The Five Things You Need to Know
The bill creates a new definition of "dispensing physician" as a medical practitioner licensed under the Medical Act, 2011 who dispenses drugs during practice.
It expands the statutory definition of "prescriber" to explicitly include pharmacists, registered nurses (under the Registered Nurses Act, 2008) and midwives (under the Health Professions Act).
New s.26(5.1) allows a pharmacist or dispensing physician to dispense drugs presented by telephone when a federal CDSA s.56(1) exemption authorizes telephone dispensing, and only for the exemption's terms and duration.
New s.26(6.1) permits a pharmacist or dispensing physician to dispense controlled‑substance prescriptions transferred from another pharmacist or dispensing physician when a federal CDSA s.56(1) exemption authorizes transfers; s.26(6.2) limits dispensing to the exemption's conditions and period.
When a prescriber's licence is suspended, cancelled, or the prescriber stops practising in the province, the prescriber must return all tamper‑resistant prescription drug pads to the minister within three days.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Adds "dispensing physician" and expands who counts as a prescriber
This provision inserts a new paragraph defining "dispensing physician" and replaces paragraph 2(p) to enumerate the professions treated as prescribers. By listing specific regulated professions, the Act removes ambiguity about whether pharmacists, registered nurses and midwives fall within the "entitled to prescribe" language. Practically, that affects who may be subject to prescriber‑specific requirements in other sections (licensing, tamper‑resistant pads, penalties). Regulatory colleges will need to map their scopes of practice to the statutory list.
Systematic replacement of gendered language and minor cross‑reference fixes
These amendments replace "his or her", "he or she", and similar phrasing with neutral expressions such as "the person", "the minister" or "the beneficiary" across multiple subsections. The text also corrects a citation to the Public Inquiries Act (now shown as the 2006 statute) and updates terms like "physicians" to "medical practitioners." These are drafting cleanups aimed at clarity; they reduce interpretive friction but do not change substantive rights or obligations other than where terminology now aligns with other Acts.
Permits telephone dispensing and transfers for controlled drugs under federal exemptions; tightens return rules
This is the operational core. New subsections (5.1) and (6.1) let pharmacists and dispensing physicians dispense drugs on the regulated list by telephone or accept transferred prescriptions for controlled substances, but only when a federal CDSA s.56(1) exemption authorizes those specific acts. Section 26(6.2) requires compliance with the exemption's terms and confines dispensing to the exemption period. The section also replaces the old pad‑return trigger with a concrete three‑day deadline when a prescriber's licence is suspended, cancelled or practice ceases — creating a rapid compliance obligation for prescribers and enforcement focus for the minister.
Procedural clarifications for appeals and absent appellants
Multiple subsections in the appeals provisions are rewritten to use neutral phrasing and to substitute precise references. Notably, the new subsection 41(7) allows the appeal board to proceed and adjudicate in the appellant's absence if the appellant fails to obtain a postponement or does not attend after being notified. That codifies an explicit route for the board to continue hearings without delay, but it also places a duty on appellants to monitor notices and secure representation where needed.
Replaces "Trial Division" with "Supreme Court" and modernizes the offence clause
Section 45 updates every reference to "Trial Division" to read "Supreme Court", aligning the Act with current judicial nomenclature. Section 47(1) is repealed and substituted with neutral, person‑based language criminalizing knowingly obtaining or receiving benefits not entitled under the Act, whether on one's own behalf or for another person. The new wording focuses on the wrongful conduct rather than the actor's gender or status.
This bill is one of many.
Codify tracks hundreds of bills on this topic across all five countries.
Explore this topic in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Patients in remote or emergent situations — federal time‑limited CDSA exemptions may now be operationalized provincially, allowing controlled drugs to be dispensed by telephone or transferred between pharmacies under narrowly defined federal authorizations, which can preserve continuity of care when normal prescribing channels are disrupted.
- Pharmacists and dispensing physicians — the statute clarifies when they may lawfully dispense controlled substances by telephone or accept transfers, reducing legal uncertainty during federal exemption periods and giving explicit statutory backing for such acts when done under the exemption's terms.
- Midwives and registered nurses with prescribing authority — inclusion in the prescriber definition aligns provincial statutory status with scopes of practice, simplifying administrative interactions (e.g., when issuing prescriptions or being subject to prescriber obligations).
- Regulatory administrators and compliance officers — gender‑neutral language and corrected cross‑references reduce interpretive ambiguity in enforcement and reporting obligations, simplifying policy implementation.
Who Bears the Cost
- Community pharmacies and dispensing physicians — they must track the existence, scope and terms of any federal CDSA s.56(1) exemption, ensure all dispensing under that exemption strictly follows conditions and time limits, and update protocols and recordkeeping accordingly.
- Small prescriber practices and individual prescribers — the three‑day pad return requirement when a licence is suspended, cancelled or practice ceases creates logistical and possibly financial burdens, particularly on solo or rural prescribers who maintain small stocks of tamper‑resistant pads.
- Provincial department/minister's office — tighter deadlines and new compliance pathways (tracking federal exemptions, enforcing three‑day returns, and processing transfers) will increase administrative oversight and may require updated guidance and IT changes.
- Professional regulatory bodies — colleges will need to reconcile their discipline and supervision rules with the expanded prescriber list and ensure members understand new return and dispensing obligations.
Key Issues
The Core Tension
The bill balances two legitimate goals that pull in opposite directions: expanding access and legal clarity (by allowing provincial actors to act under temporary federal CDSA exemptions) versus preserving controls against diversion and misuse of controlled substances (which argue for narrow, auditable exceptions and strong recordkeeping). The statute side‑steps the policy choice by deferring to federal exemptions but thereby shifts the operational burden of safely translating temporary federal authority into daily pharmacy practice.
Two implementation tensions stand out. First, the amendments create a conditional bridge to federal emergency authorities: controlled‑substance telephone dispensing and transfer are permitted only when a federal CDSA s.56(1) exemption authorizes them.
That design preserves provincial regulatory boundaries but obliges provincial actors to monitor and translate transient federal exemptions into operational pharmacy practices. The province must decide how it will notify pharmacies and prescribers of relevant federal exemptions, how to certify compliance with exemption terms, and how to audit or enforce adherence without overburdening frontline clinicians.
Second, the three‑day return requirement for tamper‑resistant pads is administratively blunt. It reduces the window during which diverted pads might circulate, but the logistical reality for small or rural prescribers — returning pads quickly, documenting returns, and replacing stock — can be burdensome.
Enforcement resources and clear procedures will determine whether the rule improves security or simply shifts compliance costs to small providers. Separately, the procedural change allowing an appeal board to proceed in an appellant's absence speeds adjudication but raises fairness questions where notice systems fail; the Act relies on accurate service and counsel availability rather than creating additional protections for unrepresented appellants.
There's more to this law than the bill.
Codify Laws traces every connection across the legislative lifecycle.